Outset Medical, Inc.OMNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR+43.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+43.5%/yr
vs -25.8%/yr prior
Acceleration
+69.3pp
Accelerating
Percentile
P74
Within normal range
vs 3Y Ago
3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 12.61% |
| Q3 2025 | -6.04% |
| Q2 2025 | 6.80% |
| Q1 2025 | -11.20% |
| Q4 2024 | -3.14% |
| Q3 2024 | -17.18% |
| Q2 2024 | -5.17% |
| Q1 2024 | -0.13% |
| Q4 2023 | -10.95% |
| Q3 2023 | 0.72% |
| Q2 2023 | 0.43% |
| Q1 2023 | 7.33% |
| Q4 2022 | 4.27% |
| Q3 2022 | -5.02% |
| Q2 2022 | 12.95% |
| Q1 2022 | -8.02% |
| Q4 2021 | 40.06% |
| Q3 2021 | 1.87% |
| Q2 2021 | 2.37% |
| Q1 2021 | -7.64% |
| Q4 2020 | -8.26% |
| Q3 2020 | 87.57% |
| Q2 2020 | 30.38% |
| Q1 2020 | 17.98% |
| Q4 2019 | 23.00% |
| Q3 2019 | 11.23% |
| Q2 2019 | 14.01% |
| Q1 2019 | 0.00% |